Regulatory science is ultimately a matter of trust. You need to trust that certain evidence, when obtained with certain methodologies, is sufficient to inform about a new medical product's safety and/or efficacy.

Viceconti M., Serigado A., Rousseau C.F., Voisin E.M. (2024). Possible Qualification Pathways for In Silico Methodologies. Berlin : Springer Cham [10.1007/978-3-031-48284-7_5].

Possible Qualification Pathways for In Silico Methodologies

Viceconti M.;
2024

Abstract

Regulatory science is ultimately a matter of trust. You need to trust that certain evidence, when obtained with certain methodologies, is sufficient to inform about a new medical product's safety and/or efficacy.
2024
Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products.
67
72
Viceconti M., Serigado A., Rousseau C.F., Voisin E.M. (2024). Possible Qualification Pathways for In Silico Methodologies. Berlin : Springer Cham [10.1007/978-3-031-48284-7_5].
Viceconti M.; Serigado A.; Rousseau C.F.; Voisin E.M.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/971678
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact